エアゾールデリバリーデバイスの世界市場2020–2027:製品別(ドライパウダー吸入薬(DPI)、定量吸入薬(MDI)、ネブライザー)、用途別、流通経路別

◆英語タイトル:Aerosol Delivery Devices Market by Product (Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs), and Nebulizers), Application (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, and Non-Respiratory Diseases), and Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and E-commerce): Global Opportunity Analysis and Industry Forecast, 2020–2027
◆商品コード:AMR20OC041
◆発行会社(リサーチ会社):Allied Market Research
◆発行日:2020年8月
◆ページ数:277
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD6,769 ⇒換算¥731,052見積依頼/購入/質問フォーム
5 UserUSD7,651 ⇒換算¥826,308見積依頼/購入/質問フォーム
Enterprise UserUSD10,670 ⇒換算¥1,152,360見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はAllied Market Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Allied Market Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、エアゾールデリバリーデバイスの世界市場を広く調査・分析し、イントロダクション、エグゼクティブサマリー、市場動向、製品別分析(ドライパウダー吸入薬(DPI)、定量吸入薬(MDI)、ネブライザー)、用途別分析(喘息、慢性閉塞性肺疾患(COPD)、嚢胞性線維症、非呼吸器疾患)、流通経路別分析(小売薬局、病院薬局、Eコマース)、地域別分析情報、競争状況、企業情報など、以下の構成でまとめております。
・イントロダクション
・エグゼクティブサマリー
・市場動向
・エアゾールデリバリーデバイスの世界市場規模:製品別(ドライパウダー吸入薬(DPI)、定量吸入薬(MDI)、ネブライザー)
・エアゾールデリバリーデバイスの世界市場規模:用途別(喘息、慢性閉塞性肺疾患(COPD)、嚢胞性線維症、非呼吸器疾患)
・エアゾールデリバリーデバイスの世界市場規模:流通経路別(小売薬局、病院薬局、Eコマース)
・エアゾールデリバリーデバイスの世界市場規模:地域別
・競争状況
・企業情報
【レポートの概要】

The global aerosol delivery devices market was valued at $31,463.9 million in 2019, and is projected to reach $46,728.7 million by 2027, registering a CAGR of 4.9% from 2020 to 2027.
Aerosol delivery devices are hand-held, portable drug delivery devices. They consist of suspension of solid or liquid particles in a carrier gas, which makes feasible for treatment of respiratory and non-respiratory diseases. There are different forms of drugs available for aerosol drug delivery such as dry powder, solution, and suspension. It is the most advanced mode of drug administration in which aerosolized drug is directly delivered to lungs to offer a systemic effect. Aerosol delivery devices are available in three types, namely, dry powder inhalers, metered dose inhalers, and nebulizers. Aerosol drug delivery is a natural therapy and easiest way to treat respiratory diseases such as asthma, COPD, and cystic fibrosis. Moreover, it is used to deliver insulin, analgesic medications, and other drugs as well.

Rise in prevalence of asthma, COPD, and other respiratory disorders, increase in smoking population, ease of administration of drug with aerosol delivery devices, rise in demand for metered-dose inhalers, technological advancements in inhaler devices, and rise in geriatric population are the key factors that fuel growth of the global aerosol delivery devices market. For instance, according to the WHO, in 2018, more than 339 million people were affected by asthma worldwide. Moreover, rise in adoption of aerosol delivery devices by patients, increase in patient awareness toward inhalation therapy, surge in preference of pulmonary route of drug delivery, rise in urbanization and pollution levels, increase in incidences of preterm births and lifestyle changes, and increase in number of R&D activities to develop ideal inhalation therapy are other factors that contribute toward growth of the market. However, complications and side-effects associated with drug inhalation and high cost associated with nebulizers are expected to hinder growth of the market.

The global aerosol delivery devices market is segmented into product, application, and distribution channel. By product, the market is categorized into dry powder inhalers, metered dose inhalers, and nebulizers. The dry powder inhalers segment is further bifurcated into single dose inhalers and multi dose inhalers. The metered dose inhalers segment is further divided into conventional pressurized inhalers and soft mist inhalers. The nebulizers segment is further categorized into jet nebulizers, ultrasonic wave nebulizers, and vibrating mesh nebulizers. On the basis of application, the market is segregated into asthma, chronic obstructive pulmonary disease, cystic fibrosis, and non-respiratory diseases. The non-respiratory diseases segment is further divided is into diabetes, analgesia, and Parkinson’s disease. Depending on distribution channel, the market is classified into retail pharmacies, hospital pharmacies, and e-commerce. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS
• The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
• It offers a quantitative analysis from 2019 to 2027, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
• A comprehensive analysis of four regions is provided to determine the existing opportunities.
• The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS
By Product
• Dry powder inhalers
o Single dose inhalers
o Multi dose inhalers
• Metered dose inhalers
o Conventional pressurized inhalers,
o Soft mist inhalers
• Nebulizers
o Jet nebulizers
o Ultrasonic wave nebulizers
o Vibrating mesh nebulizers

By Application
• Asthma
• Chronic obstructive pulmonary disease
• Cystic fibrosis
• Non respiratory diseases
o Diabetes
o Analgesia
o Parkinson’s disease

By Distribution Channel
• Retail pharmacies
• Hospital pharmacies
• E-commerce

By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o Rest of Asia-Pacific
• LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT
• 3M Company
• Aerogen, Inc.
• Glaxosmithkline Plc (GSK)
• Johnson & Johnson (Actelion Pharmaceuticals Ltd)
• Koninklijke Philips N.V.
• Merck & Co. Inc.
• Metall Zug Group (Clement Clarke International Ltd)
• Recipharm AB (Bespak)
• Teva Pharmaceutical Industries Limited
• Vectura Group Plc
• Gerresheimer AG
• Heitkamp & Thumann KG (H&T Presspart)
• Iconovo AB
• Merxin Ltd
• Nemera

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
• AstraZeneca Plc
• Boehringer Ingelheim GmbH
• Novartis AG

【レポートの目次】

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments

1.3.1.List of key players profiled in the report

1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET LANDSCAPE

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Porter’s five force analysis
3.4.Top player positioning, 2019
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Increase in air pollution
3.5.1.2.Advantages over conventional drug delivery devices
3.5.1.3.Increase in prevalence of COPD and asthma
3.5.1.4.Rise in government initiatives

3.5.2.Restraint

3.5.2.1.High cost of asthma and COPD treatments
3.5.2.2.Lack of access in underdeveloped countries

3.5.3.Opportunity

3.5.3.1.Growth opportunities in emerging markets

3.5.4.Impact analysis

3.6.Pricing analysis of aerosol delivery devices
3.7.Covid-19 Impact analysis on aerosol delivery devices market
3.8.Top manufacturers list by region
3.9.Product pipeline analysis
3.10.License terms information
3.11.Qualitative information on mass median aerodynamic diameter (MMAD)
3.12.Regulatory Information for U.S., Europe, Japan, and China: aerosol delivery sevices
3.13.Innovations in aerosol delivery devices market

CHAPTER 4:AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT

4.1.Overview

4.1.1.Market size and forecast

4.2.Dry powder inhalers (DPIs)

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.2.4.Market size and forecast, by type
4.2.5.Single dose inhalers

4.2.5.1.Market size and forecast

4.2.6.Multi dose inhalers

4.2.6.1.Market size and forecast

4.2.7.Market size and forecast, by application

4.3.Metered dose inhalers (MDIs)

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country
4.3.4.Market size and forecast, by type
4.3.5.Conventional pressurized inhalers

4.3.5.1.Market size and forecast

4.3.6.Soft mist inhalers

4.3.6.1.Market size and forecast

4.3.7.Market size and forecast, by application

4.4.Nebulizers

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country
4.4.4.Market size and forecast, by type
4.4.5.Jet nebulizers

4.4.5.1.Market size and forecast

4.4.6.Ultrasonic wave nebulizers

4.4.6.1.Market size and forecast

4.4.7.Vibrating mesh nebulizers

4.4.7.1.Market size and forecast

4.4.8.Market size and forecast, by application

CHAPTER 5:AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION

5.1.Overview

5.1.1.Market size and forecast

5.2.Asthma

5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country

5.3.Chronic obstructive pulmonary disease (COPD)

5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country

5.4.Cystic fibrosis

5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country

5.5.Non-respiratory diseases

5.5.1.Market size and forecast, by region
5.5.2.Market analysis, by country
5.5.3.Market size and forecast, by type
5.5.4.Diabetes

5.5.4.1.Market size and forecast

5.5.5.Analgesia

5.5.5.1.Market size and forecast

5.5.6.Parkinson’s disease

5.5.6.1.Market size and forecast

CHAPTER 6:AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL

6.1.Overview

6.1.1.Market size and forecast

6.2.Retail pharmacies

6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country

6.3.Hospital pharmacies

6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country

6.4.E-commerce

6.4.1.Market size and forecast, by region
6.4.2.Market analysis, by country

CHAPTER 7:AEROSOL DELIVERY DEVICES MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by country

7.2.2.1.U.S.

7.2.2.1.1.U.S. aerosol delivery devices market, by product
7.2.2.1.2.U.S. aerosol delivery devices market, by application
7.2.2.1.3.U.S. aerosol delivery devices market, by distribution channel

7.2.2.2.Canada

7.2.2.2.1.Canada aerosol delivery devices market, by product
7.2.2.2.2.Canada aerosol delivery devices market, by application
7.2.2.2.3.Canada aerosol delivery devices market, by distribution channel

7.2.2.3.Mexico

7.2.2.3.1.Mexico aerosol delivery devices market, by product
7.2.2.3.2.Mexico aerosol delivery devices market, by application
7.2.2.3.3.Mexico aerosol delivery devices market, by distribution channel

7.2.3.North America market size and forecast, by product
7.2.4.North America market size and forecast, by application
7.2.5.North America market size and forecast, by distribution channel

7.3.Europe

7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by country

7.3.2.1.Germany

7.3.2.1.1.Germany aerosol delivery devices market, by product
7.3.2.1.2.Germany aerosol delivery devices market, by application
7.3.2.1.3.Germany aerosol delivery devices market, by distribution channel

7.3.2.2.France

7.3.2.2.1.France aerosol delivery devices market, by product
7.3.2.2.2.France aerosol delivery devices market, by application
7.3.2.2.3.France aerosol delivery devices market, by distribution channel

7.3.2.3.UK

7.3.2.3.1.UK aerosol delivery devices market, by product
7.3.2.3.2.UK aerosol delivery devices market, by application
7.3.2.3.3.UK aerosol delivery devices market, by distribution channel

7.3.2.4.Italy

7.3.2.4.1.Italy aerosol delivery devices market, by product
7.3.2.4.2.Italy aerosol delivery devices market, by application
7.3.2.4.3.Italy aerosol delivery devices market, by distribution channel

7.3.2.5.Spain

7.3.2.5.1.Spain aerosol delivery devices market, by product
7.3.2.5.2.Spain aerosol delivery devices market, by application
7.3.2.5.3.Spain aerosol delivery devices market, by distribution channel

7.3.2.6.Rest of Europe

7.3.2.6.1.Rest of Europe aerosol delivery devices market, by product
7.3.2.6.2.Rest of Europe aerosol delivery devices market, by application
7.3.2.6.3.Rest of Europe aerosol delivery devices market, by distribution channel

7.3.3.Europe market size and forecast, by product
7.3.4.Europe market size and forecast, by application
7.3.5.Europe market size and forecast, by distribution channel

7.4.Asia-Pacific

7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by country

7.4.2.1.Japan

7.4.2.1.1.Japan aerosol delivery devices market, by product
7.4.2.1.2.Japan aerosol delivery devices market, by application
7.4.2.1.3.Japan aerosol delivery devices market, by distribution channel

7.4.2.2.China

7.4.2.2.1.China aerosol delivery devices market, by product
7.4.2.2.2.China aerosol delivery devices market, by application
7.4.2.2.3.China aerosol delivery devices market, by distribution channel

7.4.2.3.Australia

7.4.2.3.1.Australia aerosol delivery devices market, by product
7.4.2.3.2.Australia aerosol delivery devices market, by application
7.4.2.3.3.Australia aerosol delivery devices market, by distribution channel

7.4.2.4.India

7.4.2.4.1.India aerosol delivery devices market, by product
7.4.2.4.2.India aerosol delivery devices market, by application
7.4.2.4.3.India aerosol delivery devices market, by distribution channel

7.4.2.5.South Korea

7.4.2.5.1.South Korea aerosol delivery devices market, by product
7.4.2.5.2.South Korea aerosol delivery devices market, by application
7.4.2.5.3.South Korea aerosol delivery devices market, by distribution channel

7.4.2.6.Rest of Asia-Pacific

7.4.2.6.1.Rest of Asia-Pacific aerosol delivery devices market, by product
7.4.2.6.2.Rest of Asia-Pacific aerosol delivery devices market, by application
7.4.2.6.3.Rest of Asia-Pacific aerosol delivery devices market, by distribution channel

7.4.3.Asia-Pacific market size and forecast, by product
7.4.4.Asia-Pacific market size and forecast, by application
7.4.5.Asia-Pacific market size and forecast, by distribution channel

7.5.LAMEA

7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by country

7.5.2.1.Brazil

7.5.2.1.1.Brazil aerosol delivery devices market, by product
7.5.2.1.2.Brazil aerosol delivery devices market, by application
7.5.2.1.3.Brazil aerosol delivery devices market, by distribution channel

7.5.2.2.Saudi Arabia

7.5.2.2.1.Saudi Arabia aerosol delivery devices market, by product
7.5.2.2.2.Saudi Arabia aerosol delivery devices market, by application
7.5.2.2.3.Saudi Arabia aerosol delivery devices market, by distribution channel

7.5.2.3.South Africa

7.5.2.3.1.South Africa aerosol delivery devices market, by product
7.5.2.3.2.South Africa aerosol delivery devices market, by application
7.5.2.3.3.South Africa aerosol delivery devices market, by distribution channel

7.5.2.4.Rest of LAMEA

7.5.2.4.1.Rest of LAMEA aerosol delivery devices market, by product
7.5.2.4.2.Rest of LAMEA aerosol delivery devices market, by application
7.5.2.4.3.Rest of LAMEA aerosol delivery devices market, by distribution channel

7.5.3.LAMEA market size and forecast, by product
7.5.4.LAMEA market size and forecast, by application
7.5.5.LAMEA market size and forecast, by distribution channel

CHAPTER 8:COMPANY PROFILES

8.1.3M COMPANY

8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance

8.2.AEROGEN, INC.

8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio

8.3.GLAXOSMITHKLINE PLC (GSK)

8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance

8.4.JOHNSON & JOHNSON (ACTELION PHARMACEUTICALS LTD)

8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance
8.4.6.Key strategic moves and developments

8.5.KONINKLIJKE PHILIPS N.V.

8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance
8.5.6.Key strategic moves and developments

8.6.MERCK & CO., INC.

8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Business performance

8.7.METALL ZUG GROUP (CLEMENT CLARKE INTERNATIONAL LTD)

8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance

8.8.RECIPHARM AB (BESPAK)

8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.8.6.Key strategic moves and developments

8.9.TEVA PHARMACEUTICAL INDUSTRIES LIMITED

8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance
8.9.6.Key strategic moves and developments

8.10.VECTURA GROUP PLC

8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance
8.10.6.Key strategic moves and developments

CHAPTER 9:APPLICATION BASED COMPANY PROFILES

9.1.GERRESHEIMER AG

9.1.1.Company overview
9.1.2.Company snapshot
9.1.3.Operating business segments
9.1.4.Product portfolio
9.1.5.Business performance

9.2.HEITKAMP & THUMANN KG (H&T PRESSPART)

9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Operating business segments
9.2.4.Product portfolio

9.3.ICONOVO AB

9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Operating business segments
9.3.4.Product portfolio
9.3.5.Key strategic moves and developments

9.4.MERXIN LTD

9.4.1.Company overview
9.4.2.Company snapshot
9.4.3.Operating business segments
9.4.4.Product portfolio

9.5.NEMERA

9.5.1.Company overview
9.5.2.Company snapshot
9.5.3.Operating business segments
9.5.4.Product portfolio

LIST OF TABLES

TABLE 01.AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 02.DRY POWDER INHALERS AEROSOL DELIVERY DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 03.DRY POWDER INHALERS AEROSOL DELIVERY DEVICES MARKET, BY TYPE, 2019–2027, ($MILLION)
TABLE 04.DRY POWDER INHALERS AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 05.METERED DOSE INHALERS AEROSOL DELIVERY DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 06.METERED DOSE INHALERS AEROSOL DELIVERY DEVICES MARKET, BY TYPE, 2019–2027, ($MILLION)
TABLE 07.METERED DOSE INHALERS AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 08.NEBULIZERS AEROSOL DELIVERY DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 09.NEBULIZERS AEROSOL DELIVERY DEVICES MARKET, BY TYPE, 2019–2027, ($MILLION)
TABLE 10.NEBULIZERS AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 11.AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 12.ASTHMA AEROSOL DELIVERY DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 13.CHRONIC OBSTRUCTIVE PULMONARY DISEASE AEROSOL DELIVERY DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 14.CYSTIC FIBROSIS AEROSOL DELIVERY DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 15.NON-RESPIRATORY DISEASES AEROSOL DELIVERY DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 16.NON-RESPIRATORY DISEASES AEROSOL DELIVERY DEVICES MARKET, BY TYPE, 2019–2027, ($MILLION)
TABLE 17.AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 18.RETAIL PHARMACIES AEROSOL DELIVERY DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 19.HOSPITAL PHARMACIES AEROSOL DELIVERY DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 20.E-COMMERCE AEROSOL DELIVERY DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 21.AEROSOL DELIVERY DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 22.NORTH AMERICA AEROSOL DELIVERY DEVICES MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 23.U.S. AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 24.U.S. AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 25.U.S. AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 26.CANADA AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 27.CANADA AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 28.CANADA AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 29.MEXICO AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 30.MEXICO AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 31.MEXICO AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 32.NORTH AMERICA AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 33.NORTH AMERICA AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 34.NORTH AMERICA AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 35.EUROPE AEROSOL DELIVERY DEVICES MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 36.GERMANY AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 37.GERMANY AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 38.GERMANY AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 39.FRANCE AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 40.FRANCE AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 41.FRANCE AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 42.UK AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 43.UK AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 44.UK AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 45.ITALY AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 46.ITALY AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 47.ITALY AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 48.SPAIN AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 49.SPAIN AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 50.SPAIN AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 51.REST OF EUROPE AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 52.REST OF EUROPE AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 53.REST OF EUROPE AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 54.EUROPE AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 55.EUROPE AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 56.EUROPE AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 57.ASIA-PACIFIC AEROSOL DELIVERY DEVICES MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 58.JAPAN AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 59.JAPAN AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 60.JAPAN AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 61.CHINA AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 62.CHINA AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 63.CHINA AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 64.AUSTRALIA AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 65.AUSTRALIA AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 66.AUSTRALIA AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 67.INDIA AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 68.INDIA AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 69.INDIA AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 70.SOUTH KOREA AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 71.SOUTH KOREA AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 72.SOUTH KOREA AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 73.REST OF ASIA-PACIFIC AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 74.REST OF ASIA-PACIFIC AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 75.REST OF ASIA-PACIFIC AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 76.ASIA-PACIFIC AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 77.ASIA-PACIFIC AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 78.ASIA-PACIFIC AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 79.LAMEA AEROSOL DELIVERY DEVICES MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 80.BRAZIL AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 81.BRAZIL AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 82.BRAZIL AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 83.SAUDI ARABIA AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 84.SAUDI ARABIA AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 85.SAUDI ARABIA AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 86.SOUTH AFRICA AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 87.SOUTH AFRICA AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 88.SOUTH AFRICA AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 89.REST OF LAMEA AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 90.REST OF LAMEA AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 91.REST OF LAMEA AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 92.LAMEA AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 93.LAMEA AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 94.LAMEA AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 95.3M: COMPANY SNAPSHOT
TABLE 96.3M: OPERATING SEGMENTS
TABLE 97.3M: PRODUCT PORTFOLIO
TABLE 98.AEROGEN: COMPANY SNAPSHOT
TABLE 99.AEROGEN: PRODUCT PORTFOLIO
TABLE 100.GSK: COMPANY SNAPSHOT
TABLE 101.GLAXOSMITHKLINE PLC: OERATING SEGMENT
TABLE 102.GLAXOSMITHKLINE PLC.: PRODUCT PORTFOLIO
TABLE 103.J&J: COMPANY SNAPSHOT
TABLE 104.J&J: OPERATING SEGMENTS
TABLE 105.JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
TABLE 106.J&J: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 107.PHILIPS: COMPANY SNAPSHOT
TABLE 108.PHILIPS: OERATING SEGMENT
TABLE 109.PHILIPS: PRODUCT PORTFOLIO
TABLE 110.PHILIPS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 111.MERCK & CO., INC.: COMPANY SNAPSHOT
TABLE 112.MERCK & CO., INC.: OPERATING SEGMENTS
TABLE 113.MERCK & CO., INC.: PRODUCT PORTFOLIO
TABLE 114.METALL ZUG: COMPANY SNAPSHOT
TABLE 115.METALL ZUG: OERATING SEGMENT
TABLE 116.METALL ZUG: PRODUCT PORTFOLIO
TABLE 117.RECIPHARM: COMPANY SNAPSHOT
TABLE 118.RECIPHARM: OERATING SEGMENT
TABLE 119.RECIPHARM: PRODUCT PORTFOLIO
TABLE 120.RECIPHARM: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 121.TEVA: COMPANY SNAPSHOT
TABLE 122.TEVA: PRODUCT PORTFOLIO
TABLE 123.TEVA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 124.VECTURA: COMPANY SNAPSHOT
TABLE 125.VECTURA: PRODUCT PORTFOLIO
TABLE 126.VECTURA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 127.GERRESHEIMER: COMPANY SNAPSHOT
TABLE 128.GERRESHEIMER: OERATING SEGMENT
TABLE 129.GERRESHEIMER: PRODUCT PORTFOLIO
TABLE 130.HEITKAMP & THUMANN: COMPANY SNAPSHOT
TABLE 131.HEITKAMP & THUMANN: OERATING SEGMENT
TABLE 132.HEITKAMP & THUMANN.: PRODUCT PORTFOLIO
TABLE 133.ICONOVO: COMPANY SNAPSHOT
TABLE 134.ICONOVO: PRODUCT PORTFOLIO
TABLE 135.ICONOVO: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 136.MERXIN: COMPANY SNAPSHOT
TABLE 137.MERXIN.: PRODUCT PORTFOLIO
TABLE 138.NEMARA: COMPANY SNAPSHOT
TABLE 139.NEMARA.: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.GLOBAL AEROSOL DELIVERY DEVICES MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2017–2019
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2017–2019
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2017–2019
FIGURE 06.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.HIGH THREAT OF SUBSTITUTES
FIGURE 09.MODERATE THREAT OF NEW ENTRANTS
FIGURE 10.HIGH INTENSITY OF RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2019
FIGURE 12.IMPACT ANALYSIS:
FIGURE 13.COMPARATIVE ANALYSIS OF DRY POWDER INHALERS AEROSOL DELIVERY DEVICES MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 14.SINGLE DOSE INHALERS MARKET, 2019–2027, ($MILLION)
FIGURE 15.MULTI DOSE INHALERS MARKET, 2019–2027, ($MILLION)
FIGURE 16.COMPARATIVE ANALYSIS OF METERED DOSE INHALERS AEROSOL DELIVERY DEVICES MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 17.CONVENTIONAL PRESSURIZED INHALERS MARKET, 2019–2027, ($MILLION)
FIGURE 18.SOFT MIST INHALERS MARKET, 2019–2027, ($MILLION)
FIGURE 19.COMPARATIVE ANALYSIS OF NEBULIZERS AEROSOL DELIVERY DEVICES MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 20.JET NEBULIZERS MARKET, 2019–2027, ($MILLION)
FIGURE 21.ULTRASONIC WAVE NEBULIZERS MARKET, 2019–2027, ($MILLION)
FIGURE 22.VIBRATING MESH NEBULIZERS MARKET, 2019–2027, ($MILLION)
FIGURE 23.COMPARATIVE ANALYSIS OF ASTHMA AEROSOL DELIVERY DEVICES MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 24.COMPARATIVE ANALYSIS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AEROSOL DELIVERY DEVICES MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 25.COMPARATIVE ANALYSIS OF CYSTIC FIBROSIS AEROSOL DELIVERY DEVICES MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 26.COMPARATIVE ANALYSIS OF NON-RESPIRATORY DISEASES AEROSOL DELIVERY DEVICES MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 27.DIABETES MARKET, 2019–2027, ($MILLION)
FIGURE 28.ANALGESIA MARKET, 2019–2027, ($MILLION)
FIGURE 29.PARKINSON'S DISEASE MARKET, 2019–2027, ($MILLION)
FIGURE 30.COMPARATIVE ANALYSIS OF RETAIL PHARMACIES AEROSOL DELIVERY DEVICES MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 31.COMPARATIVE ANALYSIS OF HOSPITAL PHARMACIES AEROSOL DELIVERY DEVICES MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 32.COMPARATIVE ANALYSIS OF E-COMMERCE AEROSOL DELIVERY DEVICES MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 33.3M: NET SALES, 2017–2019 ($MILLION)
FIGURE 34.3M: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 35.3M: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 36.GSK: TURNOVER:, 2017–2019 ($MILLION)
FIGURE 37.GSK: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 38.GSK: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 39.J&J: NET SALES, 2017–2019 ($MILLION)
FIGURE 40.J&J: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 41.J&J: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 42.PHILIPS: NET SALES, 2017–2019 ($MILLION)
FIGURE 43.PHILIPS: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 44.PHILIPS: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 45.MERCK & CO., INC.: NET SALES, 2017–2019 ($MILLION)
FIGURE 46.MERCK & CO., INC.: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 47.MERCK & CO., INC.: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 48.METALL ZUG: NET SALES, 2017–2019 ($MILLION)
FIGURE 49.METALL ZUG: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 50.METALL ZUG: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 51.RECIPHARM: NET SALES, 2017–2019 ($MILLION)
FIGURE 52.RECIPHARM: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 53.RECIPHARM: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 54.TEVA: NET SALES, 2017–2019 ($MILLION)
FIGURE 55.VECTURA: NET SALES, 2017–2019 ($MILLION)
FIGURE 56.VECTURA: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 57.GERRESHEIMER: NET SALES, 2017–2019 ($MILLION)
FIGURE 58.GERRESHEIMER: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 59.GERRESHEIMER: REVENUE SHARE, BY REGION, 2019 (%)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[エアゾールデリバリーデバイスの世界市場2020–2027:製品別(ドライパウダー吸入薬(DPI)、定量吸入薬(MDI)、ネブライザー)、用途別、流通経路別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆